Plante Moran Financial Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-50
Closed -$9K – 953
2022
Q3
$9K Hold
50
– – ﹤0.01% 602
2022
Q2
$8K Hold
50
– – ﹤0.01% 652
2022
Q1
$9K Hold
50
– – ﹤0.01% 613
2021
Q4
$13K Hold
50
– – ﹤0.01% 643
2021
Q3
$14K Hold
50
– – ﹤0.01% 639
2021
Q2
$10K Hold
50
– – ﹤0.01% 682
2021
Q1
$10K Buy
+50
New +$10.3K ﹤0.01% 650

Other funds holding RGEN

Plante Moran Financial Advisors's RGEN Position: Q4 2022 in Review

Plante Moran Financial Advisors sold out of Repligen (RGEN) in Q4 2022, closing a stake of 50 shares — an estimated $9K sold.

Plante Moran Financial Advisors first reported a position in RGEN in Q1 2021 and held it in 7 quarters. The position peaked at $14K in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • Plante Moran Financial Advisors reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 50 Repligen shares in Q4 2022, an estimated $9K.
  • Plante Moran Financial Advisors first reported a position in Repligen in Q1 2021 and held it in 7 quarters.
  • Plante Moran Financial Advisors's Repligen position peaked at $14K in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on Plante Moran Financial Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.